PI3K/Akt regulates survival during differentiation of human macrophages by maintaining NF-κB-dependent expression of antiapoptotic Bcl-xL

J Leukoc Biol. 2014 Dec;96(6):1011-22. doi: 10.1189/jlb.1A0414-212R. Epub 2014 Sep 15.

Abstract

Resistance to apoptosis is an important characteristic that human macrophages acquire during differentiation from monocytes. However, the intracellular mechanisms that mediate the development of resistance are not well understood. We have used M-CSF-stimulated primary human monocytes and PMA-treated THP1 cells to study apoptosis resistance during differentiation of human macrophages. Our results indicate that PI3K/Akt distinctively regulates survival of macrophages during and after differentiation. More specifically, a signaling pathway consisting of PI3K/Akt-NF-κB-Bcl-xL regulates cell survival during the differentiation process. PI3K/Akt-mediated activation of NF-κB plays a key role in survival of differentiating macrophages by specifically sustaining antiapoptotic Bcl-xL expression. With the use of pharmacological inhibitors and siRNA for Akt and Bcl-xL, we show that in the absence of Akt-dependent Bcl-xL expression during differentiation, cells undergo caspase-mediated apoptosis. In contrast, in differentiated macrophages, Bcl-xL expression is independent of PI3K/Akt activation. Taken together, these results suggest that survival of macrophages is distinctly regulated during and after differentiation. Our results also suggest new, potential therapeutic targets to modulate differentiation and survival of this cell type.

Keywords: apoptosis; cell survival; innate immunity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthracenes / pharmacology
  • Apoptosis / drug effects
  • Caffeic Acids / pharmacology
  • Cell Line, Tumor
  • Chromones / pharmacology
  • Flavonoids / pharmacology
  • Gene Expression Regulation, Developmental
  • Hematopoiesis / genetics*
  • Humans
  • MAP Kinase Signaling System / drug effects
  • Macrophage Colony-Stimulating Factor / pharmacology
  • Macrophages / cytology*
  • Macrophages / drug effects
  • Monocytes / cytology
  • Monocytes / drug effects
  • Morpholines / pharmacology
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / physiology*
  • Phenylethyl Alcohol / analogs & derivatives
  • Phenylethyl Alcohol / pharmacology
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / physiology*
  • RNA, Small Interfering / pharmacology
  • Sesquiterpenes / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Tetradecanoylphorbol Acetate / pharmacology
  • bcl-X Protein / biosynthesis
  • bcl-X Protein / genetics
  • bcl-X Protein / physiology*

Substances

  • Anthracenes
  • BCL2L1 protein, human
  • Caffeic Acids
  • Chromones
  • Flavonoids
  • Morpholines
  • NF-kappa B
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • RNA, Small Interfering
  • Sesquiterpenes
  • bcl-X Protein
  • pyrazolanthrone
  • parthenolide
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Macrophage Colony-Stimulating Factor
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt
  • caffeic acid phenethyl ester
  • Phenylethyl Alcohol
  • Tetradecanoylphorbol Acetate
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one